Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1648, 2008-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Candesartan cilexetil + lisinopril superior to monotherapies?
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :
Candesartan cilexetil CHARMing in chronic HF with low LVEF
Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. :
Candesartan cilexetil may prevent diabetes in patients with HF
Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. :
Candesartan: a new DIRECTion for diabetic retinopathy?
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Losartan more cost effective than candesartan - or is it?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. :